David Venet

11PUBLICATIONS
114CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersGene and molecular therapyCognition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 25, 2026
Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER<sup>+</sup>HER2<sup>-</sup> breast cancer: a randomized phase 2 trial.

|Dec 22, 2025
Molecular and Clinical Analyses of Gene Fusions Identify Therapeutic Targets in Paired Primary and Metastatic Breast Cancer from the AURORA Program (BIG 14-01).

Chiara Biagioni, Danai Fimereli, Alexandre Irrthum

|May 16, 2025
Unraveling the Tumor Microenvironment and PD-L1 Expression across Tissue Types in High-Grade Serous Ovarian Cancer in the NeoPembrOV/GINECO Phase II Randomized Trial.

Laetitia Collet, Maude Ardin, David Venet

|Oct 29, 2024
Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: An Analysis of the ZEPHIR Clinical Trial.

Mattia Rediti, Danai Fimereli, Magdalena Mileva

|Sep 21, 2023
Differential Benefit of Metronomic Chemotherapy Among Triple-Negative Breast Cancer Subtypes Treated in the IBCSG Trial 22-00.

Andrea Joaquin Garcia, Mattia Rediti, David Venet

|Jan 26, 2023
Reply to S. Di Cosimo et al.

Elisa Agostinetto, David Venet, Michail Ignatiadis

Pageof 2

Frequent Collaborators

8 joint publications

Christos Sotiriou

4 joint publications

Elisa Agostinetto

3 joint publications

Mattia Rediti

3 joint publications

Sherene Loi